Opening book details…
About this Medicine article
2139 CONSIGN: An open-label phase 3B study of regorafenib in patients with metastatic colorectal cancer (mCRC) who failed standard therapy by Van Cutsem, E.; Ciardiello, F.; Seitz, J.F.; Hofheinz, R.D.; Verma, U.; Garcia-Carbonero, R.; Grothey, A.; Miriyala, A.; Kalmus, J.; Shapiro, J.; Falcone, A.; Zaniboni, A. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Van Cutsem, E.; Ciardiello, F.; Seitz, J.F.; Hofheinz, R.D.; Verma, U.; Garcia-Carbonero, R.; Grothey, A.; Miriyala, A.; Kalmus, J.; Shapiro, J.; Falcone, A.; Zaniboni, A.
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0959-8049)
- Published
- 2015
- Language
- EN
- Field
- Medicine (Health Sciences)